Related content

A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors

By Yan Zhao   Zhu Zhongling   Li Kai   Chen Peng   Wang Liuchun   Huang Chun   Xue Jinhuai   Liu Meijun  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 955-961

Springer Publishing Company

Access to resources Recommend Favorite

Value of pharmacokinetic studies for patients with gastrointestinal stromal tumors

By De Giorgi Ugo  

Future Oncology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1675-1677

Future Medicine

Access to resources Recommend Favorite

Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug–drug interaction potential

By LoRusso Patricia   Piha-Paul Sarina   Mita Monica   Colevas A.   Malhi Vikram   Colburn Dawn   Yin Ming   Low Jennifer   Graham Richard  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 193-202

Springer Publishing Company

Access to resources Recommend Favorite

Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme

By Raymond E.   Campone M.   Stupp R.   Menten J.   Chollet P.   Lesimple T.   Fety-Deporte R.   Lacombe D.   Paoletti X.   Fumoleau P.   for the EORTC Early Clinical Studies Group ECSG B.T.S.G..a.N.D.D.P..  

European Journal of Cancer, Vol. 38, Iss. 10, 2002-07 ,pp. : 1348-1350

Elsevier

Access to resources Recommend Favorite

Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors

By  

The Oncologist, Vol. 23, Iss. 2, 2018-02 ,pp. : 155-e17

John Wiley & Sons Inc

Access to resources Recommend Favorite